Stockscreener 앱 받기
7.28
1.22%
-0.09
시장 영업 전:
7.06
-0.22
-3.02%
전일 마감가:
$7.37
열려 있는:
$7.39
하루 거래량:
185.50K
Relative Volume:
1.08
시가총액:
$363.65M
수익:
-
순이익/손실:
$-76.41M
주가수익비율:
-3.7917
EPS:
-1.92
순현금흐름:
$-64.56M
1주 성능:
-4.84%
1개월 성능:
-7.73%
6개월 성능:
-4.08%
1년 성능:
-18.11%
1일 변동 폭
$7.2526
$7.63
1주일 범위
$7.2526
$7.805
52주 변동 폭
$6.63
$12.38
Aura Biosciences Inc Stock (AURA) Company Profile
명칭
Aura Biosciences Inc
전화
(617)500-8864
주소
80 GUEST STREET, BOSTON
AURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
7.28 | 363.65M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
480.35 | 123.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
723.47 | 79.09B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.94 | 37.97B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.20 | 31.74B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
259.70 | 27.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 개시 | H.C. Wainwright | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2022-07-19 | 개시 | JMP Securities | Mkt Outperform |
Aura Biosciences Inc 주식(AURA)의 최신 뉴스
How to Take Advantage of moves in (AURA) - Stock Traders Daily
Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Brokerages Set Aura Biosciences, Inc. (NASDAQ:AURA) Target Price at $23.00 - Defense World
Aura Biosciences CEO sells shares worth $156,795 - Investing.com India
Aura Biosciences CTO sells shares for $16,670 By Investing.com - Investing.com South Africa
Aura Biosciences chief medical officer sells $19,638 in stock By Investing.com - Investing.com Canada
Aura Biosciences senior VP sells $10,881 in stock to cover taxes - Investing.com
Aura Biosciences chief medical officer sells $19,638 in stock - Investing.com
Aura Biosciences Executives Sell Shares to Cover Tax Obligations - TradingView
Non-Muscle Invasive Bladder Cancer (NMIBC) Drugs Market 2034: - openPR
Healthy Upside Potential: Aura Biosciences Inc (AURA) - SETE News
How To Trade (AURA) - Stock Traders Daily
FY2025 Earnings Estimate for AURA Issued By Leerink Partnrs - MarketBeat
Ocular melanoma Market Expected to Experience Major Growth - openPR
AURAAura Energy Limited September 2020 Quarterly Report (5044E) - br.ADVFN.com
Q1 Earnings Estimate for AURA Issued By Leerink Partnrs - MarketBeat
What is Leerink Partnrs’ Estimate for AURA FY2025 Earnings? - Defense World
Research Analysts Issue Forecasts for AURA Q1 Earnings - Defense World
CV Sciences Unveils New Aura Collection THC Fizz Tablets - Yahoo Finance
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update - MarketBeat
Aura Biosciences (NASDAQ:AURA) Rating Increased to Strong-Buy at Lifesci Capital - MarketBeat
Lifesci Capital Upgrades Aura Biosciences (NASDAQ:AURA) to Strong-Buy - Defense World
Investing in Aura Minerals (TSE:ORA) five years ago would have delivered you a 822% gain - Yahoo Finance
JPMorgan Chase & Co. Grows Holdings in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Financial Analysis: New Concept Energy (NYSE:GBR) versus Riley Exploration Permian (NYSE:REPX) - Defense World
Waystar (NASDAQ:WAY) & Verint Systems (NASDAQ:VRNT) Critical Review - Defense World
Head-To-Head Contrast: Yara International ASA (OTCMKTS:YARIY) vs. Ero Copper (NYSE:ERO) - Defense World
Analysts Set Aura Biosciences, Inc. (NASDAQ:AURA) PT at $23.00 - Defense World
Regency Capital Management Inc. DE Sells 57,887 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) Receives $23.00 Average Target Price from Brokerages - MarketBeat
What is Lifesci Capital’s Estimate for AURA FY2024 Earnings? - Defense World
FY2024 Earnings Forecast for AURA Issued By Lifesci Capital - MarketBeat
Non Muscle Invasive Bladder Cancer Pipeline 2024: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Aura Biosciences, Protara Therapeutics, Vaxiion Therapeutics - Barchart
This Insider Has Just Sold Shares In Aura Biosciences - Simply Wall St
Where are the Opportunities in (AURA) - Stock Traders Daily
Non Muscle Invasive Bladder Cancer Pipeline 2024: MOA, ROA, - openPR
Aura Biosciences VP Amy Elazzouzi sells $7,679 in stock - MSN
Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells $122,374.85 in Stock - MarketBeat
Aura Biosciences CEO Elisabet de los Pinos sells shares worth $122,381 - MSN
Aura Biosciences VP Amy Elazzouzi sells $7,679 in stock By Investing.com - Investing.com Australia
Barclays PLC Acquires 43,897 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat
Cool Company Ltd. (NYSE:CLCO) Shares Purchased by Barclays PLC - Defense World
Barclays PLC Has $544,000 Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Omeros (NASDAQ:OMER) Earns “Buy” Rating from D. Boral Capital - Defense World
(AURA) Trading Signals - Stock Traders Daily
Jane Street Group LLC Decreases Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Aura completes acquisition of Bluestone - Yahoo Finance
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Long Focus Capital Management, LLC Increases Stake in Aura Biosc - GuruFocus.com
Analysts Set Planet Labs PBC (NYSE:PL) Target Price at $4.33 - Defense World
Aura Biosciences Inc (AURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
0.33%
자본화:
|
볼륨(24시간):